|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/519 | |||
| A61P 19/00 | |||
| A61K 31/506 |
| (11) | Number of the document | 2790718 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12799204.8 |
| Date of filing the European patent application | 2012-12-12 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/075294 |
| Date | 2012-12-12 |
| (87) | Number | WO 2013/087725 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| PCT/IB2011/0032 | 2011-12-12 | WO |
| (72) |
LEGEAI-MALLET, Laurence, FR
MUNNICH, Arnold, FR
BUSCA, Patricia, FR
BARBAULT, Florent, FR
|
| (73) |
Université Paris Descartes,
12, rue de l`Ecole de Médecine, 75006 Paris,
FR
Centre National de la Recherche Scientifique (C.N.R.S.), 3, rue Michel-Ange, 75016 Paris, FR Université Paris Diderot - Paris 7, 5, rue Thomas Mann, 75013 Paris, FR Institut National de la Santé et de la Recherche Médicale (INSERM), 101, rue de Tolbiac, 75013 Paris, FR Assistance Publique Hōpitaux de Paris, 3 Avenue Victoria, 75004 Paris, FR Imagine, 24, Boulevard du Montparnasse, 75015 Paris, FR |
| (54) | ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3 |
| ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3 |